Despite a lagging share price, the company has ambitious goals.
News & Analysis: Tilray, Inc.
According to quarterly 13-F filings, Wall Street rang the register on these popular marijuana stocks.
Here's a look at Tilray's recent performance compared with its largest competitors.
Pot stocks were more concerned with supporting inflated valuations than meeting grow expectations, according to this prominent cannabis CEO.
Marijuana stock upgrades have been few and far between, especially for this popular player.
Cannabis company Tilray's latest financial report includes plenty of pros and cons.
But there are also two reasons that it might not.
Sales growth aside, this was another subpar quarter for the sixth-largest pot stock.
TLRY earnings call for the period ending March 31, 2019.
Stocks rose for a second day on trade hopes, with Macy's and marijuana specialist Tilray reporting earnings.